Schizophrenia study finds new biomarker, drug candidate to treat cognitive symptoms Large study was in human cerebral spinal fluid and mouse models

#Schizophrenia study reveals a new #biomarker for diagnosing the disorder; a form of the #brain protein called #Cacna2d1 is reduced in patients with the condition, which results in overstimulated neural circuitry.
news.northwestern.edu/stories/2026...